← Eichor
Study identifier: NCT04523701 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)

Condition: Bile Leakage  ·  Sponsor: Giulia Manzini

PhasePhase 3
Planned participants210
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Bile leakage (BL) is the most frequent complication after liver resection. This study is to investigate the role of intraoperative administration of SMOFlipid 20% (fat emulsion which allows intraoperative identification of open bile ducts at the liver resection surface when it is administered retrograde through the cystic duct) in terms of prevention of postoperative BL within 30 days after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Giulia Manzini, Dr. med.  ·  +41-62-8389734  ·  giulia.manzini@ksa.ch

Always discuss trial participation with your own doctor first.

Locations (5)

Department of Visceral Surgery, Cantonal Hospital of AarauAarau, SwitzerlandRecruiting
Clarunis Basel, Universitäres Bauchzentrum BaselBasel, SwitzerlandRecruiting
Kantonsspital LuzernLucerne, SwitzerlandRecruiting
Ospedale Regionale di LuganoLugano, SwitzerlandRecruiting
Kantonsspital St. GallenSankt Gallen, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04523701